Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Atzpodien

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|July 3, 2003
Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcomeJ Atzpodien, Th Küchler, T Wandert, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Immunogenicity of recombinant human interleukin-2: biological features and clinical relevanceE L Hänninen, J Knüver-Hopf, J Atzpodien
British Journal of Cancer|November 1, 2007
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patientsJ Atzpodien, K Terfloth, M Fluck, et al.
British Journal of Cancer|February 6, 2003
Metastatic renal carcinoma comprehensive prognostic systemJ Atzpodien, P Royston, T Wandert, et al.
Cancer Research|October 1, 1986
Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrowJ Atzpodien, S C Gulati, B D Clarkson
Pediatric Hematology and Oncology|July 1, 1991
Fosfomycin does not reduce cytostatic activity of cis-platinum against human osteosarcoma cell lines in vitroC Bührer, J Atzpodien, S Oz, et al.
Experimental Hematology|November 1, 1990
A highly sensitive quantitative bioassay for human granulocyte-macrophage colony-stimulating factorS Oez, C Bührer, J Atzpodien, et al.
Cancer Research|September 15, 1987
Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemiaD Wisniewski, A Strife, J Atzpodien, et al.
Blood|August 1, 1987
Photoradiation models for the clinical ex vivo treatment of autologous bone marrow graftsJ Atzpodien, S C Gulati, A Strife, et al.
Der Urologe. Ausg. A|September 29, 1999
[Chemoimmunotherapy in the systemic treatment of advanced renal carcinoma]J Atzpodien, J Buer, S Sel, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|July 3, 2003
Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcomeJ Atzpodien, Th Küchler, T Wandert, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Immunogenicity of recombinant human interleukin-2: biological features and clinical relevanceE L Hänninen, J Knüver-Hopf, J Atzpodien
British Journal of Cancer|November 1, 2007
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patientsJ Atzpodien, K Terfloth, M Fluck, et al.
British Journal of Cancer|February 6, 2003
Metastatic renal carcinoma comprehensive prognostic systemJ Atzpodien, P Royston, T Wandert, et al.
Cancer Research|October 1, 1986
Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrowJ Atzpodien, S C Gulati, B D Clarkson
Pediatric Hematology and Oncology|July 1, 1991
Fosfomycin does not reduce cytostatic activity of cis-platinum against human osteosarcoma cell lines in vitroC Bührer, J Atzpodien, S Oz, et al.
Experimental Hematology|November 1, 1990
A highly sensitive quantitative bioassay for human granulocyte-macrophage colony-stimulating factorS Oez, C Bührer, J Atzpodien, et al.
Cancer Research|September 15, 1987
Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemiaD Wisniewski, A Strife, J Atzpodien, et al.
Blood|August 1, 1987
Photoradiation models for the clinical ex vivo treatment of autologous bone marrow graftsJ Atzpodien, S C Gulati, A Strife, et al.
Der Urologe. Ausg. A|September 29, 1999
[Chemoimmunotherapy in the systemic treatment of advanced renal carcinoma]J Atzpodien, J Buer, S Sel, et al.
Pageof 12